Health systems modeller and health economist; Green Party councillor for Birkenhead and Tranmere

Wirral, Uk
Joined September 2009
Today's Lancet climate and health report presents 56 indicators of health and climate change across FIVE domains. (Download the report for free from the Lancet website). Here is a thread of some of the key findings. #Lancetclimate24 (1)
39
1,334
136
2,530
422,936
Fantastic PharmacoEconomics article by @Ewmoto, Eve Worrall & @lstmnews team, rethinking #TB morbidity quantification. Disability weights essential for TB DALY calculations but, with gaps in current approaches, this review asks "what are we weighting for?" link.springer.com/article/10…
7
14
675
Ewan M Tomeny retweeted
Health Economic results from the Stage 2 STREAM #ClinicalTrial have been published today in @LancetGH. @BertieSquire, @eworrall1, @JasonMadan, @laura_rosu1, @ewmoto. Find out more: rb.gy/uhwyq7
4
8
6
19
6,157
Happy to share our study in @GlobalHealthBMJ contributing valuable evidence to post-TB morbidity agenda from a longitudinal post-treatment cohort.@beckyn_respPT @1Gn1991 @JasonMadan @eworrall1 @ChakayaJm @JamieRylance @BertieSquire @LSTMnews #postTB #DALY gh.bmj.com/content/7/5/e0076…
1
12
1
27
Tao Chen & colleagues estimate the cost-effectiveness of intensive blood pressure intervention in Chinese populations at high risk for #CardiovascularDisease plos.io/2OJUk0n
1
1
Ewan M Tomeny retweeted
Wrapping up #WorldTBDay2021 with the recording of #LSTM's virtual seminar: Prof @BertieSquire, @laura_rosu1, Ewan Tomeny & an international panel of experts on 'About time: Advancing the clinical & public health management of drug resistant #tuberculosis bit.ly/3ckJxTD
2
5
An important piece from my colleague Dr Obasi.
(1/3) Reposted as 3 linked tweets: I am writing in @TheLancet about academia but the message - #NoExcellenceWithoutEquity- applies to all sectors where measures of “Excellence” are blind to fairness or inclusion. thelancet.com/journals/lance…
2
1
4
Ewan M Tomeny retweeted
#STREAM1 paper, the first ever within-trial economic evaluation of shortened regimen for #DRTB has been published today in @WHOBulletin
Shortened multidrug resistant #tuberculosis (MDR-TB) regimen reduces costs for health systems by 21 to 25% per patient and helps patients return to work, study shows. bit.ly/3f7WQ94 #endTB #DRTB, #costeffectiveness, #patientcosts
2
7